Skip to content

Clinical trials

Agammaglobulinemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agammaglobulinemia Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20061
20102
20122
20131
20143
20161
20191
20202
20211
20222
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Terminated2
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)4
Kedrion S.p.A.3
CSL Behring2
Grifols Therapeutics LLC2
M.D. Anderson Cancer Center2
Octapharma2
Advanced Neurosciences Institute1
Bio Products Laboratory1
Brigham and Women's Hospital1
BriovaRx Infusion Services1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agammaglobulinemia25
Immunologic Deficiency Syndromes7
Primary Immunodeficiency Diseases7
Common Variable Immunodeficiency5
Leukemia, Lymphocytic, Chronic, B-Cell5
Infections4
Warts3
Bacterial Infections2
Multiple Myeloma2
Neutropenia2

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.